myricanol has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abisambra, JF; Baker, BJ; Blair, L; Davey, Z; Dickey, CA; Eckman, CB; Jinwal, UK; Johnson, AG; Jones, JR; Koren, J; Lebar, MD; O'Leary, JC; Trotter, J; Weeber, E | 1 |
1 other study(ies) available for myricanol and Alzheimer Disease
| Article | Year |
|---|---|
The diarylheptanoid (+)-aR,11S-myricanol and two flavones from bayberry (Myrica cerifera) destabilize the microtubule-associated protein tau.
Topics: Alzheimer Disease; Animals; Diarylheptanoids; Female; Flavonoids; HeLa Cells; Humans; Male; Mice; Models, Biological; Myrica; Plant Roots; Prosencephalon; tau Proteins | 2011 |